Sort by
Refine Your Search
-
fixed-term period of 3 years with the possibility of a 4th year with compulsory other work (e.g. teaching duties at the Department). The position is subject to financing by the University of Bergen and is
-
at the University of Bergen has a vacancy for a fixed-term 3 year PhD position in applied and computational mathematics. The position is part of the Norwegian Research Council funded Center for Sustainable Subsurface
-
subject to financing by the University of Bergen and is affiliated with the Fish Health research group , and Sea Lice Research Center . About the project/work tasks: One of the biggest challenges for salmon
-
the Lynagh group at the Michael Sars Centre . The position is for a fixed-term period of 4 years. The Centre belongs to the University of Bergen and is a partner of the European Molecular Biology Laboratory
-
Informatics - Computational Biology at the Department of Informatics at the University of Bergen. The position is for a period of 14 months and is associated with the project “New technologies for target
-
Receptors. There is a vacancy for a PhD Research Fellow in the Lynagh group at the Michael Sars Centre . The position is for a fixed-term period of 4 years. The Centre belongs to the University of Bergen and
-
for Responsible Media Technology & Innovation at the Department of Information Science and Media Studies, University of Bergen. This is a temporary project position for 2 years. MediaFutures is a centre for
-
. The position is associated with the large, interdisciplinary research project "Hub Molecules of Life" (HubMOL), which is jointly financed by the Research Council of Norway (RCN) and the University of Bergen
-
27 May 2024 Job Information Organisation/Company University of Bergen Department Department of Biomedicine Research Field Biological sciences Medical sciences Researcher Profile Recognised
-
collaboration with a research group at Stanford University and ”System dynamics approach Using Chemical Compounds to Elucidate the Structure of Polycystic Ovarian Syndrome (SUCCESS)”, financed by Novo Nordisk